Literature DB >> 10649502

Identification of three novel mutations of the palmitoyl-protein thioesterase-1 (PPT1) gene in children with neuronal ceroid-lipofuscinosis.

S Waliany1, A K Das, A Gaben, K E Wisniewski, S L Hofmann.   

Abstract

Eight unrelated children with progressive neurological deterioration and granular osmiophilic deposits (GROD) due to an underlying palmitoyl-protein thioesterase deficiency were analyzed for mutations in the PPT1 gene. Three novel mutations (G118D, Q291X and F84del) were identified. The novel Q291X mutation was observed in an African-American child. The G118D and Q291X mutations occurred in infantile-onset subjects. These two mutations would be predicted to have severe effects on enzyme activity. The novel F84del mutation involves an invariant phenylalanine residue. A missense mutation, Q177E, occurred in three subjects from two families with late-infantile NCL, confirming an association of the Q177E mutation with a late-infantile phenotype. Other previously described mutations were R151X (5/16 alleles), T75P (3/16 alleles), R164X (1/16 alleles), and V181M (1/16 alleles). The current study expands the spectrum of mutations in PPT1 deficiency and further confirms the broad range of age of onset of symptoms resulting from an enzyme deficiency previously associated only with infantile NCL. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10649502     DOI: 10.1002/(SICI)1098-1004(200002)15:2<206::AID-HUMU14>3.0.CO;2-L

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis.

Authors:  J J Bellizzi; J Widom; C Kemp; J Y Lu; A K Das; S L Hofmann; J Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.

Authors:  N D Schmitt; J N Agar
Journal:  J Mass Spectrom       Date:  2017-07       Impact factor: 1.982

3.  A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Authors:  Judith A Hobert; Glyn Dawson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

4.  The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.

Authors:  Jake N Miller; Attila D Kovács; David A Pearce
Journal:  Hum Mol Genet       Date:  2014-09-08       Impact factor: 6.150

Review 5.  Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis.

Authors:  Nima Naseri; Manu Sharma; Milen Velinov
Journal:  Clin Genet       Date:  2020-08-26       Impact factor: 4.438

6.  Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients.

Authors:  Jayesh Sheth; Mehul Mistri; Riddhi Bhavsar; Dhairya Pancholi; Mahesh Kamate; Neerja Gupta; Madhulika Kabra; Sanjiv Mehta; Sheela Nampoothiri; Arpita Thakker; Vivek Jain; Raju Shah; Frenny Sheth
Journal:  BMC Neurol       Date:  2018-12-12       Impact factor: 2.903

7.  High diagnostic yield of direct Sanger sequencing in the diagnosis of neuronal ceroid lipofuscinoses.

Authors:  Abdulhakim Jilani; Diana Matviychuk; Susan Blaser; Sarah Dyack; Jean Mathieu; Asuri N Prasad; Chitra Prasad; Lianna Kyriakopoulou; Saadet Mercimek-Andrews
Journal:  JIMD Rep       Date:  2019-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.